BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CAMTA1, ENSG00000171735, 23261, Q9Y6Y1, KIAA0833
9 results:

  • 1. WWTR1(TAZ)-camta1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
    Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
    Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. camta1, a novel antitumor gene, regulates proliferation and the cell cycle in glioma by inhibiting AKT phosphorylation.
    He Z; Yang C; He Y; Gong B; Yin C; Feng J; Chen L; Tang J; Chen Y
    Cell Signal; 2021 Mar; 79():109882. PubMed ID: 33316386
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Case of Large Meningeal Epithelioid Hemangioendothelioma With WWTR1-camta1 Gene Rearrangement and Slow Growth Over 15 Years.
    Süß P; Volz F; Lang C; Staszewksi O; Palmedo G; Taschner CA; Scheiwe C; Kurz P; Mentzel T; Prinz M
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):871-876. PubMed ID: 30085199
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.
    Perry KD; Al-Lbraheemi A; Rubin BP; Jen J; Ren H; Jang JS; Nair A; Davila J; Pambuccian S; Horvai A; Sukov W; Tazelaar HD; Folpe AL
    Mod Pathol; 2017 Nov; 30(11):1589-1602. PubMed ID: 28731049
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear Expression of camta1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
    Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
    Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
    Baronchelli S; Bentivegna A; Redaelli S; Riva G; Butta V; Paoletta L; Isimbaldi G; Miozzo M; Tabano S; Daga A; Marubbi D; Cattaneo M; Biunno I; Dalprà L
    PLoS One; 2013; 8(2):e57462. PubMed ID: 23468990
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.
    Tanas MR; Sboner A; Oliveira AM; Erickson-Johnson MR; Hespelt J; Hanwright PJ; Flanagan J; Luo Y; Fenwick K; Natrajan R; Mitsopoulos C; Zvelebil M; Hoch BL; Weiss SW; Debiec-Rychter M; Sciot R; West RB; Lazar AJ; Ashworth A; Reis-Filho JS; Lord CJ; Gerstein MB; Rubin MA; Rubin BP
    Sci Transl Med; 2011 Aug; 3(98):98ra82. PubMed ID: 21885404
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of camta1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.